Ligand-induced ErbB receptor dimerization

被引:169
作者
Lemmon, Mark A. [1 ]
机构
[1] Univ Penn, Sch Med, Stellar Chance Labs 809C, Dept Biochem & Biophys, Philadelphia, PA 19104 USA
关键词
Epidermal growth factor receptor; Receptor tyrosine kinase; ErbB receptor; Cooperativity; Receptor dimerization; Crystal structure; Heterodimer; Autoinhibition; Ligand binding; Allostery; EPIDERMAL-GROWTH-FACTOR; AFFINITY INSULIN-BINDING; TYROSINE KINASE-ACTIVITY; EXTRACELLULAR DOMAIN; EGF RECEPTOR; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; CELL-SURFACE; NEGATIVE COOPERATIVITY; TRANSMEMBRANE DOMAINS;
D O I
10.1016/j.yexcr.2008.10.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Structural studies have provided important new insights into how ligand binding promotes homodimerization and activation of the EGF receptor and the other members of the ErbB family of receptor tyrosine kinases. These structures have also suggested possible explanations for the unique properties of ErbB2, which has no known ligand and can cause cell transformation (and tumorigenesis) by simple overexpression. In parallel with these advances, studies of the EGF receptor at the cell surface increasingly argue that the structural studies are missing key mechanistic components. This is particularly evident in the structural prediction that EGF binding linked to receptor dimerization should be positively cooperative, whereas cell-surface EGF-binding studies suggest negative cooperativity. In this review, I summarize studies of ErbB receptor extracellular regions in solution and of intact receptors at the cell surface, and attempt to reconcile the differences suggested by the two approaches. By combining results obtained with receptor 'parts', it is qualitatively possible to explain some models for the properties of the whole receptor. These considerations underline the need to consider the intact ErbB receptors as intact allosterically regulated enzymes, and to combine cellular and structural studies into a complete picture. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:638 / 648
页数:11
相关论文
共 100 条
  • [1] Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth
    Agus, DB
    Akita, RW
    Fox, WD
    Lewis, GD
    Higgins, B
    Pisacane, PI
    Lofgren, JA
    Tindell, C
    Evans, DP
    Maiese, K
    Scher, HI
    Sliwkowski, MX
    [J]. CANCER CELL, 2002, 2 (02) : 127 - 137
  • [2] Fusion of insulin receptor ectodomains to immunoglobulin constant domains reproduces high-affinity insulin binding in vitro
    Bass, J
    Kurose, T
    Pashmforoush, M
    Steiner, DF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) : 19367 - 19375
  • [3] HIGH-AFFINITY EPIDERMAL GROWTH-FACTOR BINDING IS SPECIFICALLY REDUCED BY A MONOCLONAL-ANTIBODY, AND APPEARS NECESSARY FOR EARLY RESPONSES
    BELLOT, F
    MOOLENAAR, W
    KRIS, R
    MIRAKHUR, B
    VERLAAN, I
    ULLRICH, A
    SCHLESSINGER, J
    FELDER, S
    [J]. JOURNAL OF CELL BIOLOGY, 1990, 110 (02) : 491 - 502
  • [4] Disabling receptor ensembles with rationally designed interface peptidomimetics
    Berezov, A
    Chen, JQ
    Liu, QD
    Zhang, HT
    Greene, MI
    Murali, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (31) : 28330 - 28339
  • [5] ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface
    Berger, MB
    Mendrola, JM
    Lemmon, MA
    [J]. FEBS LETTERS, 2004, 569 (1-3): : 332 - 336
  • [6] BOSE R, 2008, EXP CELL RES, DOI DOI 10.1016/J.YEXCR.2008.1007.1031
  • [7] The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand
    Bouyain, S
    Longo, PA
    Li, SQ
    Ferguson, KM
    Leahy, DJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (42) : 15024 - 15029
  • [8] An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors
    Burgess, AW
    Cho, HS
    Eigenbrot, C
    Ferguson, KM
    Garrett, TPJ
    Leahy, DJ
    Lemmon, MA
    Sliwkowski, MX
    Ward, CW
    Yokoyama, S
    [J]. MOLECULAR CELL, 2003, 12 (03) : 541 - 552
  • [9] CARPENTER CD, 1991, J BIOL CHEM, V266, P5750
  • [10] ErbB-4: mechanism of action and biology
    Carpenter, G
    [J]. EXPERIMENTAL CELL RESEARCH, 2003, 284 (01) : 66 - 77